| Hans-Günter Meyer-Thompson | international
Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky.
Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky.
Lei F, Lofwall MR, Freeman PR, Slade E, Vickers-Smith R, Slavova S.
J Rural Health. 2022 May 24. doi: 10.1111/jrh.12669. Epub ahead of print. PMID: 35610181.